SCHEMBL20230645

SCHEMBL20230645

CC1(C)c2ccccc2C(c2ccc3c(c2)[Si](C)(C)c2cc(-c4nc(-c5ccccc5)c5ccccc5n4)ccc2O3)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
ATM Q13315 1/20 0.41
CYP1A2 P05177 7/20 0.35
CYP3A4 P08684 7/20 0.35
CYP2D6 P10635 7/20 0.35
CYP2C19 P33261 7/20 0.35
HSD17B10 Q99714 7/20 0.35
USP2 O75604 6/20 0.35
CLK4 Q9HAZ1 6/20 0.35
ALOX15 P16050 4/20 0.35
LMNA P02545 4/20 0.35
CYP2C9 P11712 2/20 0.35
WHR1 P49842 1/20 0.34
MAPK1 P28482 4/20 0.33
TSHR P16473 3/20 0.33
ADORA2A P29274 3/20 0.32
NUDT1 P36639 3/20 0.32
PDE10A Q9Y233 2/20 0.31
ALDH1A1 P00352 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20230611 0.89 MEN1 (0.44) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL20230578 0.87 MEN1 (0.44) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL20230632 0.86 MEN1 (0.36) MEN1KMT2ACYP2C19LMNAADORA2A
SCHEMBL20230634 0.84 MEN1 (0.38) MEN1KMT2ACYP2C19LMNAADORA2A
SCHEMBL22871832 0.82 KMT2A (0.37) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL20230592 0.79 MEN1 (0.44) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL24138940 0.78 MEN1 (0.48) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL24138826 0.76 MEN1 (0.48) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL20230701 0.76 MEN1 (0.38) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL24293189 0.75 MEN1 (0.45) MEN1KMT2AATMCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 MEN1 666/4885KMT2A 1608/4885ATM 3323/4885
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 MEN1 666/4885KMT2A 1608/4885ATM 3323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.